PRUVN’s Post

View organization page for PRUVN, graphic

282 followers

Our first double-blinded, placebo-controlled human clinical trial results are public! 📰 This study, conducted at the University of Santa Catarina, measured the effects of RiboCeine supplementation on serum glutathione levels. RiboCeine is a patented compound found in Max International products. The results: 250mg of RiboCeine supplementation over 28 days increased blood serum glutathione levels in the intervention group by 26% while it dropped 3% in the placebo group. The effect was more pronounced in older participants where blood serum levels were measured to increase by 64% (in 51-60 year olds). Conclusion: In this preliminary trial, RiboCeine supplementation elevated blood serum glutathione levels, with a more pronounced effect in older participants.* Congratulations to our entire team, especially Francisco Cidral, ND, PhD who led the research. 🥼 *Further research is required with larger sample sizes to conclusively determine RiboCeine’s efficacy in enhancing glutathione levels and its potential age-related benefits. Read the full release below: #PRUVN #research #science #glutathione #supplements #nutraceuticals #evidence #clinicaltrial #PR #pressrelease #results #bloodtesting https://lnkd.in/dhNSdmBQ

PRUVN Reveals Human Clinical Trial Results of Max International's RiboCeine™ Supplementation's Impact on Serum Glutathione Levels

PRUVN Reveals Human Clinical Trial Results of Max International's RiboCeine™ Supplementation's Impact on Serum Glutathione Levels

prnewswire.com

Francisco J. Martínez-Calderón

𝙀𝙣𝙩𝙧𝙚𝙥𝙧𝙚𝙣𝙚𝙪𝙧 🌎🌍🌏

3mo

This is very impressive!!! RiboCeine 💯

Like
Reply

To view or add a comment, sign in

Explore topics